VTRS

Viatris (VTRS)

Viatris Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VTRS

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
21/05/2024	12h59	PR Newswire (US)	Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale	NASDAQ:VTRS	Viatris Inc
09/05/2024	13h47	IH Market News	U.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%	NASDAQ:VTRS	Viatris Inc
09/05/2024	13h44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTRS	Viatris Inc
09/05/2024	12h59	PR Newswire (US)	Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges	NASDAQ:VTRS	Viatris Inc
02/05/2024	23h00	PR Newswire (US)	Viatris to Participate in the BofA Securities 2024 Health Care Conference	NASDAQ:VTRS	Viatris Inc
01/05/2024	12h59	PR Newswire (US)	Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health	NASDAQ:VTRS	Viatris Inc
16/04/2024	22h30	PR Newswire (US)	Viatris to Report First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:VTRS	Viatris Inc
15/04/2024	14h00	PR Newswire (US)	Viatris Appoints Corinne Le Goff as Chief Commercial Officer	NASDAQ:VTRS	Viatris Inc
15/04/2024	12h59	PR Newswire (Canada)	Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada	NASDAQ:VTRS	Viatris Inc
15/04/2024	12h59	PR Newswire (Canada)	Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au Canada	NASDAQ:VTRS	Viatris Inc
01/04/2024	12h59	PR Newswire (US)	Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States	NASDAQ:VTRS	Viatris Inc
27/03/2024	11h59	PR Newswire (US)	Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline	NASDAQ:VTRS	Viatris Inc
06/03/2024	02h29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
06/03/2024	02h24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
06/03/2024	02h09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
06/03/2024	01h54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
06/03/2024	01h47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
06/03/2024	01h26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
05/03/2024	00h11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTRS	Viatris Inc
28/02/2024	13h39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTRS	Viatris Inc
28/02/2024	12h30	PR Newswire (US)	Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance	NASDAQ:VTRS	Viatris Inc
28/02/2024	07h00	PR Newswire (US)	Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration	NASDAQ:VTRS	Viatris Inc
24/02/2024	00h00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
17/02/2024	00h00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
15/02/2024	23h18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTRS	Viatris Inc
05/02/2024	12h59	PR Newswire (US)	Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results	NASDAQ:VTRS	Viatris Inc
30/01/2024	22h40	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:VTRS	Viatris Inc
19/01/2024	12h56	PR Newswire (US)	Viatris recognised as a Top Employer 2024 in the UK for the second consecutive year	NASDAQ:VTRS	Viatris Inc
06/01/2024	00h00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTRS	Viatris Inc
05/01/2024	02h28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTRS	Viatris Inc